SETD2 Antikörper (N-Term)
Kurzübersicht für SETD2 Antikörper (N-Term) (ABIN925965)
Target
Alle SETD2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Ratte (Rattus), Hund
-
Immunogen
- SETD2 antibody was raised in rabbit using the N terminal of SETD2 as the immunogen
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator.
-
Kommentare
-
SETD2 Blocking Peptide, (ABIN5616078), is also available for use as a blocking control in assays to test for specificity of this SETD2 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 100 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- SETD2 (SET Domain Containing 2 (SETD2))
-
Andere Bezeichnung
- SETD2
-
Hintergrund
- Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. SETD2 is a protein belonging to a class of huntingtin interacting proteins characterized by WW motifs. Synonyms: Polyclonal SETD2 antibody, Anti-SETD2 antibody, SET domain containing 2 antibody, FLJ16420 antibody, FLJ22472 antibody, FLJ23184 antibody, FLJ45883 antibody, HIF-1 antibody, HSPC069 antibody, HYPB antibody, KIAA1732 antibody, KMT3A antibody.
-
Pathways
- Tube Formation
Target
-